189 related articles for article (PubMed ID: 26369579)
1. Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiency.
Schneider HJ; Buchfelder M; Wallaschofski H; Luger A; Johannsson G; Kann PH; Mattsson A
Eur J Endocrinol; 2015 Dec; 173(6):843-51. PubMed ID: 26369579
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
[TBL] [Abstract][Full Text] [Related]
3. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
4. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
5. Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak.
Feldt-Rasmussen U; Brabant G; Maiter D; Jonsson B; Toogood A; Koltowska-Haggstrom M; Rasmussen AK; Buchfelder M; Saller B; Biller BM
Eur J Endocrinol; 2013 May; 168(5):733-43. PubMed ID: 23416951
[TBL] [Abstract][Full Text] [Related]
6. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
[TBL] [Abstract][Full Text] [Related]
8. GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database.
Gardner CJ; Mattsson AF; Daousi C; Korbonits M; Koltowska-Haggstrom M; Cuthbertson DJ
Eur J Endocrinol; 2015 Apr; 172(4):371-81. PubMed ID: 25583905
[TBL] [Abstract][Full Text] [Related]
9. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania.
Moock J; Albrecht C; Friedrich N; Völzke H; Nauck M; Koltowska-Haggström M; Kohlmann T; Wallaschofski H
Eur J Endocrinol; 2009 Jan; 160(1):17-24. PubMed ID: 18974232
[TBL] [Abstract][Full Text] [Related]
11. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
[TBL] [Abstract][Full Text] [Related]
12. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.
Spielhagen C; Schwahn C; Möller K; Friedrich N; Kohlmann T; Moock J; Kołtowska-Häggström M; Nauck M; Buchfelder M; Wallaschofski H
Growth Horm IGF Res; 2011 Feb; 21(1):1-10. PubMed ID: 21093334
[TBL] [Abstract][Full Text] [Related]
13. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
[TBL] [Abstract][Full Text] [Related]
14. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.
Svensson J; Mattsson A; Rosén T; Wirén L; Johannsson G; Bengtsson BA; Koltowska Häggström M;
Growth Horm IGF Res; 2004 Jun; 14(3):207-15. PubMed ID: 15125882
[TBL] [Abstract][Full Text] [Related]
15. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
Rizzo M; Trepp R; Berneis K; Christ ER
Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
[TBL] [Abstract][Full Text] [Related]
16. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
[TBL] [Abstract][Full Text] [Related]
17. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.
Hoybye C; Jönsson P; Monson JP; Koltowska-Häggström M; Hána V; Geffner M; Abs R
Eur J Endocrinol; 2007 Nov; 157(5):589-96. PubMed ID: 17984238
[TBL] [Abstract][Full Text] [Related]
18. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
[TBL] [Abstract][Full Text] [Related]
19. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
[TBL] [Abstract][Full Text] [Related]
20. Three-year experience with access to nationally funded growth hormone (GH) replacement for GH-deficient adults.
Holdaway IM; Hunt P; Manning P; Cutfield W; Gamble G; Ninow N; Staples-Moon D; Moodie P; Metcalfe S
Clin Endocrinol (Oxf); 2015 Jul; 83(1):85-90. PubMed ID: 25523467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
